Document is current
Any future updates will be listed below
-
Authors
Zenere, Alberto
Hellberg, Sandra
Papapavlou Lingehed, Georgia
Svenvik, Maria
Mellergård, Johan
Dahle, Charlotte
Vrethem, Magnus
Raffetseder, Johanna
Khademi, Mohsen
Olsson, Tomas
Blomberg, Marie
Jenmalm, Maria C.
Altafini, Claudio
Gustafsson, Mika
Ernerudh, Jan
-
Funding
Funding for this research was provided by:
Neuroförbundet (F2018-0052)
Forskningsrådet i Sydöstra Sverige (FORSS-315121)
Region Östergötland
MS Forskningsfonden
Stiftelsen för Strategisk Forskning (SB16-0011)
Vetenskapsrådet (2018-02776)
ALF grants
Linköping University
- License Information
-
More Information
Article History
Received: 17 October 2022
Accepted: 17 April 2023
First Online: 27 April 2023
Declarations
:
: The study was performed in accordance with the Helsinki Declaration’s ethical principles for medical research and was approved by the Regional ethical review board in Linköping (2012/402–31). All participants signed informed consent.
: Not applicable.
: TO has received honoraria for advisory boards/lectures from Biogen, Merck, Novartis and Sanofi. The same companies have provided unrestricted MS research grants, none of which has dealt with the current manuscript. TO has grant support from the Swedish research Council, the Swedish Brain foundation, Knut and Alice Wallenbergs foundation and Margaretha af Ugglas foundation.
